Form 4: IGM Biosciences Director Jakob Haldor Topsoe Reports Acquisition of Common Stock

Director Jakob Haldor Topsoe reports acquiring 1,734 shares of IGM Biosciences common stock through fully vested restricted stock units.

Summary

• On September 30, 2024, Jakob Haldor Topsoe, a director of IGM Biosciences, acquired 1,734 shares of common stock.
• The acquisition was through fully vested restricted stock units (RSUs), with each RSU representing a contingent right to receive one share of IGM Biosciences common stock.
• The shares were acquired at a price of $0.
• Following the transaction, Topsoe directly owns 88,322 shares of IGM Biosciences common stock.
• Topsoe also indirectly owns 10,400,564 shares through Topsoe Holding A/S.
• Other members of the board of directors of Topsoe Holding A/S may be deemed to share voting and investment power with respect to the shares reported herein and disclaim beneficial ownership of such shares, except to the extent of his or her pecuniary interest therein, if any.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document is a standard regulatory filing reporting a transaction by a company director.

Positives

• The acquisition of shares by a director may be viewed positively by investors as it signals confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in the company's stock.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment.

Key Dates